Court Sides with Cardiovalve in Edwards patent spat

Contributed by: PR Newswire

Tags

VenusMedtechCardioVal

More Like This

Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations

PR Newswire associated0

Venus Medtech VenusP-Valve transcatheter pulmonic valve replacement system granted Health Canada approval

Venus Medtech's Exciting Innovations for Structural Heart to Be Showcased at London Valves 2023

PR Newswire associated0

Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.

PR Newswire associated0

Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study

PR Newswire associated0

Peijia Medical Announces 2025 Interim Results

Business Wire embedded0

CroíValve Announces $16 Million Equity Financing to Fund US Early Feasibility Study of Novel Transcatheter Tricuspid Device

PR Newswire associated0

Meril Champions Innovation with Myval Octapro THV Launch at GISE 2024 & PCR LondonValves 2024